ClinicalTrials.govpublic full text
Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms.
gastroesophageal reflux, heartburn, nocturnal heartburn, day-time heartburn, rabeprazole, gerd, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 831305
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.